American Association for Cancer Research (AACR) Special Conference in Cancer Research: Fusion-Positive Cancers is organized by American Association for Cancer Research (AACR) and will be held from Jan 13 - 15, 2026 at Hilton Philadelphia at Penn's Landing, Philadelphia, Pennsylvania, United States of America.
Description:
Hosted by the American Association for Cancer Research (AACR), the AACR Special Conference on Fusion-Positive Cancers 2026 will bring together leading researchers, clinicians, and translational scientists to discuss the latest advances in fusion oncogene biology, carcinogenesis, and targeted therapeutic strategies. This premier event will explore the genetic and molecular mechanisms driving fusion-driven malignancies, highlighting key topics such as tumor modeling, condensate biology, gene regulatory networks, and novel therapeutic approaches, including small molecule inhibitors, targeted protein degradation, and CRISPR-based technologies. Through plenary sessions, keynote lectures, and poster presentations, attendees will engage in discussions on how cutting-edge research is shaping the future of fusion-positive cancer diagnosis and treatment.
Understanding fusion-driven cancers requires a multidisciplinary approach, integrating insights from basic science, translational research, and clinical advancements. The conference will feature sessions on the discovery of new oncogenic drivers, mechanisms of transcriptional dysregulation, and emerging therapeutic opportunities for both pediatric and adult fusion-driven cancers. Experts will also present on the clinical translation of novel therapeutics, early-phase clinical trials, and personalized treatment strategies. This meeting provides a unique platform for collaboration and scientific exchange, fostering innovation and accelerating progress toward more effective treatments for patients with fusion-positive cancers.
Additional details will be posted as soon as information is available.
Copyrights © 2026 eMedEvents Corporation, All Rights Reserved